Clinical risk management of herb-drug interactions.

There is no fulltext present in this item.

Title:	Clinical risk management of herb-drug interactions.
Author(s):	Smet, P.A.G.M. de
Publication year:	2007
Source:	British Journal of Clinical Pharmacology, vol. 63, iss. 3, (2007), pp. 258-267
ISSN:	0306-5251
DOI:	https://doi.org/10.1111/j.1365-2125.2006.02797.x
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/52712
Display more details
Subject:	CTR 2: Clinical Pharmacology and physiology EBP 4: Quality of Care N4i 1: Pathogenesis and modulation of inflammation N4i 3: Poverty-related infectious diseases NCEBP 3: Implementation Science UMCN 3.2: Cognitive neurosciences CTR 2: Clinical Pharmacology and physiology
Organization:	Clinical Pharmacy
Journal title:	British Journal of Clinical Pharmacology
Volume:	vol. 63
Issue:	iss. 3
Page start:	p. 258
Page end:	p. 267
Abstract:	The concomitant use of conventional and herbal medicines can lead to clinically relevant herb-drug interactions. Clinical risk management offers a systematic approach to minimize the untoward consequences of these interactions by paying attention to: (i) risk identification and assessment; (ii) development and execution of risk reduction strategies; and (iii) evaluation of risk reduction strategies. This paper reviews which steps should be explored or taken in these domains to improve the clinical risk management of adverse herb-drug interactions.